The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

While the broader market slides and AI darlings lose ground, Ford and GM are bucking the trend in afternoon trading, and the ...

UnitedHealth raised its 2026 adjusted EPS guidance from $19.50-$20.00 to at least $20.50. With $18.30 already earned through ...

Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look ...

PNC Financial Services delivered a mixed Q3 2026 performance that underscores the divergence between profitability momentum ...

Medpace is rated Sell, with a $484.49 fair value versus a $612.05 close—implying a 26.33% premium. Click to read more about ...

Alphabet's cloud backlog just hit $514 billion and CEO Sundar Pichai is growing more bullish by the day, yet the stock barely ...

Insteel Industries (IIIN) possesses the right combination of the two key ingredients for a likely earnings beat in its ...

A new study finds that three-layer prefabricated composite wall panels cut on-site construction energy use by 27.3 percent ...

You get what you pay for” often applies to expensive stocks with best-in-class business models and execution. While their ...

Visa's stock surged 9% in October, nearing record highs after China's central bank approved its domestic bankcard clearing ...

Fifth Third's Q3 2026 revenue ($3.34B) and EPS ($1.08) growth stem from its $10.9B Comerica acquisition, not organic ...